Special AT-rich sequence binding protein 1 expression correlates with response to preoperative radiotherapy and clinical outcome in rectal cancer

References

• Gellad ZF, Provenzale D. Colorectal cancer: national and international perspective on the burden of disease and public health impact. Gastroenterology 2010; 138(6):2177-90; PMID:20420954; http://dx.doi.org/10.1053/j.gastro.2010.01.056
   PubMed Web of Science ®Google Scholar
• Bolderson E, Richard DJ, Zhou BB, Khanna KK. Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair. Clin Cancer Res 2009; 15(20):6314-20; PMID:19808869; http://dx.doi.org/10.1158/1078-0432.CCR-09-0096
   PubMed Web of Science ®Google Scholar
• Campos EI, Reinberg D. Histones: annotating chromatin. Annu Rev Genet 2009; 43:559-99; PMID:19886812; http://dx.doi.org/10.1146/annurev.genet.032608.103928
   PubMed Web of Science ®Google Scholar
• Cann KL, Dellaire G. Heterochromatin and the DNA damage response: the need to relax. Biochem Cell Biol 2011; 89(1):45-60; PMID:21326362; http://dx.doi.org/10.1139/O10-113
   PubMed Web of Science ®Google Scholar
• Takata H, Hanafusa T, Mori T, Shimura M, Iida Y, Ishikawa K, Yoshikawa K, Yoshikawa Y, Maeshima K. Chromatin compaction protects genomic DNA from radiation damage. PLoS One 2013; 8(10):e75622; PMID:24130727; http://dx.doi.org/10.1371/journal.pone.0075622
   PubMed Web of Science ®Google Scholar
• Cai S, Han HJ, Kohwi-Shigematsu T. Tissue specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 2003; 34(1):42-51; PMID:12692553; http://dx.doi.org/10.1038/ng1146
   PubMed Web of Science ®Google Scholar
• Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T. SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 2002; 419(6907):641-5; PMID:12374985; http://dx.doi.org/10.1038/nature01084
   PubMed Web of Science ®Google Scholar
• Kumar PP, Purbey PK, Sinha CK, Notani D, Limaye A, Jayani RS, Galande S. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol Cell 2006; 22(2):231-43; PMID:16630892; http://dx.doi.org/10.1016/j.molcel.2006.03.010
   PubMed Web of Science ®Google Scholar
• Kumar PP, Mehta S, Purbey PK, Notani D, Jayani RS, Purohit HJ, Raje DV, Ravi DS, Bhonde RR, Mitra D, Galande S. SATB1-binding sequences and Alu-like motifs define a unique chromatin context in the vicinity of human immunodeficiency virus type 1 integration sites. J Virol 2007; 81(11):5617-27; PMID:17376900; http://dx.doi.org/10.1128/JVI.01405-06
   PubMed Web of Science ®Google Scholar
• Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008; 452(7184):187-93; PMID:18337816; http://dx.doi.org/10.1038/nature06781
   PubMed Web of Science ®Google Scholar
• Zhao XD, Ji WY, Zhang W, He LX, Yang J, Liang HJ, Wang LL. Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2010; 72(1):1-5; PMID:20110741; http://dx.doi.org/10.1159/000264777
   PubMed Web of Science ®Google Scholar
• Lu, X, Cheng C, Zhu S, Yang Y, Zheng L, Wang G, Shu X, Wu K, Liu K, Tong Q. SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep 2010; 24(4):981-7; PMID:20811679
   PubMed Web of Science ®Google Scholar
• Cheng C, Lu X, Wang G, Zheng L, Shu X, Zhu S, Liu K, Wu K, Tong Q. Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS 2010; 118(11):855-63; PMID:20955458; http://dx.doi.org/10.1111/j.1600-0463.2010.02673.x
   PubMed Web of Science ®Google Scholar
• Iorns E, Hnatyszyn HJ, Seo P, Clarke J, Ward T, Lippman M. The role of SATB1 in breast cancer pathogenesis. J Natl Cancer Inst 2010; 102(16):1284-96; PMID:20595686; http://dx.doi.org/10.1093/jnci/djq243
   PubMed Web of Science ®Google Scholar
• Li K, Cai R, Dai BB, Zhang XQ, Wang HJ, Ge SF, Xu WR, Lu J. SATB1 regulates SPARC expression in K562 cell line through binding to a specific sequence in the third intron. Biochem Biophys Res Commun 2007; 356(1):6-12; PMID:17343824; http://dx.doi.org/10.1016/j.bbrc.2007.01.201
   PubMed Web of Science ®Google Scholar
• Agrelo R, Souabni A, Novatchkova M, Haslinger C, Leeb M, Komnenovic V, Kishimoto H, Gresh L, Kohwi-Shigematsu T, Kenner L, Wutz A. SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells. Dev Cell 2009; 16(4): 507-16; PMID:19386260; http://dx.doi.org/10.1016/j.devcel.2009.03.006
   PubMed Web of Science ®Google Scholar
• Steidl U, Steidl C, Ebralidze A, Chapuy B, Han HJ, Will B, Rosenbauer F, Becker A, Wagner K, Koschmieder S, et al. A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia. J Clin Invest 2007; 117(9):2611-20; PMID:17694175; http://dx.doi.org/10.1172/JCI30525
   PubMed Web of Science ®Google Scholar
• Meng WJ, Yan H, Zhou B, Zhang W, Kong XH, Wang R, Zhan L, Li Y, Zhou ZG, Sun XF. Correlation of SATB1 overexpression with the progression of human rectal cancer. Int J Colorectal Dis 2012; 27(2):143-50; PMID:21870058; http://dx.doi.org/10.1007/s00384-011-1302-9
   PubMed Web of Science ®Google Scholar
• Nodin B, Johannesson H, Wangefjord S, O'Connor DP, Lindquist KE, Uhlén M, Jirström K, Eberhard J. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer. Diagn Pathol 2012; 7:115; PMID:22935204; http://dx.doi.org/10.1186/1746-1596-7-115
   PubMed Web of Science ®Google Scholar
• Tu W, Luo M, Wang Z, Yan W, Xia Y, Deng H, He J, Han P, Tian D. Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer. Liver Int 2012; 32(7): 1064-78; PMID:22583549; http://dx.doi.org/10.1111/j.1478-3231.2012.02815.x
   PubMed Web of Science ®Google Scholar
• Hanker LC, Karn T, Mavrova-Risteska L, Ruckhäberle E, Gaetje R, Holtrich U, Kaufmann M, Rody A, Wiegratz I. SATB1 gene expression and breast cancer prognosis. Breast 2011; 20(4):309-13; PMID:20980149; http://dx.doi.org/10.1016/j.breast.2010.10.002
   PubMed Web of Science ®Google Scholar
• Selinger CI, Cooper WA, Al-Sohaily S, Mladenova DN, Pangon L, Kennedy CW, McCaughan BC, Stirzaker C, Kohonen-Corish MR. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. J Thorac Oncol 2010; 6(7):1179-89; http://dx.doi.org/10.1097/JTO.0b013e31821b4ce0
   Web of Science ®Google Scholar
• Al-Sohaily S, Henderson C, Selinger C, Pangon L, Segelov E, Kohonen-Corish MR, Warusavitarne J. Loss of special AT-rich sequence-binding protein 1 (SATB1) predicts poor survival in patients with colorectal cancer. Histopathology 2014; 65(2):155-63; PMID:24118100; http://dx.doi.org/10.1111/his.12295
   PubMed Web of Science ®Google Scholar
• No authors listed. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336(14):980-7; PMID:9091798; http://dx.doi.org/10.1056/NEJM199704033361402.
   PubMed Web of Science ®Google Scholar
• Knutsen A, Adell G, Sun XF. Inflammatory infiltration, fibrosis, necrosis and mucinous content in relation to clinicopathological and molecular factors in rectal cancers with or without preoperative radiotherapy. Oncol Rep 2006; 16(2):321-7; PMID:16820910
   PubMed Web of Science ®Google Scholar
• Jansson A, Sun XF. Ki-67 expression in relation to clinicopathological variables and prognosis in colorectal adenocarcinomas. APMIS 1997; 105(9):730-4; PMID:9350218; http://dx.doi.org/10.1111/j.1699-0463.1997.tb05078.x
   PubMed Web of Science ®Google Scholar
• Adell G, Sun XF, Stål O, Klintenberg C, Sjödahl R, Nordenskjöld B. p53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer. Radiother Oncol 1999; 51(2):169-74; PMID:10435809; http://dx.doi.org/10.1016/S0167-8140(99)00041-9
   PubMed Web of Science ®Google Scholar
• Sun XF. p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma. Clin Cancer Res 2012; 8(1):165-70.
   Google Scholar
• Arlehag L, Adell G, Knutsen A, Thorstenson S, Sun XF. ATM expression in rectal cancers with or without preoperative radiotherapy. Oncol Rep 2005; 14(2):313-7; PMID:16012708
   PubMed Web of Science ®Google Scholar
• Loftås P, Onnesjö S, Widegren E, Adell G, Kayed H, Kleeff J, Zentgraf H, Sun XF. Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2009; 75(1):137-42; http://dx.doi.org/10.1016/j.ijrobp.2008.10.076
   PubMed Web of Science ®Google Scholar
• Moparthi SB, Bergman V, Adell G, Thorstensson S, Sun XF. pRb2/p130 protein in relation to clinicopathological and biological variables in rectal cancers with a clinical trial of preoperative radiotherapy. Int J Colorectal Dis 2009; 24(11):1303-10; PMID:19597825; http://dx.doi.org/10.1007/s00384-009-0767-2
   PubMed Web of Science ®Google Scholar
• Moparthi SB Arbman G, Wallin A, Kayed H, Kleeff J, Zentgraf H, Sun XF. Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers. Int J Oncol 2007; 30(1):91-5; PMID:17143516
   PubMed Web of Science ®Google Scholar
• Knutsen A, Adell G, Sun XF. Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2004; 60(1):149-55; PMID:15337550; http://dx.doi.org/10.1016/j.ijrobp.2004.02.007
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang B, Zhang X, Sun Y, Wei X, McNutt MA, Lu S, Liu Y, Zhang D, Wang M, Lin Z, Niu N. SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo. PLoS One 2013; 8(1):e47902; PMID:23326301; http://dx.doi.org/10.1371/journal.pone.0047902
   PubMedGoogle Scholar
• Squatrito M, Brennan CW, Helmy K, Huse JT, Petrini JH, Holland EC. Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas. Cancer Cell 2010; 18(6):619-29; PMID:21156285; http://dx.doi.org/10.1016/j.ccr.2010.10.034
   PubMed Web of Science ®Google Scholar
• Carson-Walter EB, Winans BN, Whiteman MC, Liu Y, Jarvela S, Haapasalo H, Tyler BM, Huso DL, Johnson MD, Walter KA. Characterization of TEM1/endosialin in human and murine brain tumors. BMC Cancer 2009; 9:417; PMID:19948061; http://dx.doi.org/10.1186/1471-2407-9-417
   PubMed Web of Science ®Google Scholar
• Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421(6922):499-506; PMID:12556884; http://dx.doi.org/10.1038/nature01368
   PubMed Web of Science ®Google Scholar
• Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003; 3(3):155-68; PMID:12612651; http://dx.doi.org/10.1038/nrc1011
   PubMed Web of Science ®Google Scholar
• Montoya-Durango DE, Ramos KS. Retinoblastoma family of proteins and chromatin epigenetics: a repetitive story in a few LINEs. BioMol Concepts 2011; 2(4):233-45; PMID:25962032
   PubMedGoogle Scholar